Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 905 of 6351
-
New lotion could ease rare skin disorder
Disease control OngoingThis study has been designed to determine the safety, tolerability and efficacy of QRX003 lotion 2%, 4% QAM or 4% BID in subjects with Netherton Syndrome (NS) in comparison to vehicle
Phase 2/3 • Sponsor: Quoin Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Bladder cancer breakthrough? drug combo aims to stop tumors returning
Disease control Recruiting nowThis is a phase II randomized controlled clinical trial comparing standard induction BCG versus bicalutamide and standard induction BCG among patients with non-muscle invasive bladder cancer.
Phase 2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can a new injection tame Gout's uric acid?
Disease control CompletedStudy YDHY (HZBio1)-001 (Ib/Ⅱ) is an open-label, dose-escalation and expansion, multicenter Phase Ib/II clinical trial conducted in China. The primary objectives were to evaluate the safety, tolerability, and PK of multiple-dose administration of HZBio1. The secondary objectives …
Phase 1/2 • Sponsor: Hangzhou Grand Biologic Pharmaceutical, Inc. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can needles quiet chronic pelvic pain?
Symptom relief CompletedBackground: Vulvodynia and chronic pelvic pain (CPP) are common and challenging gynecologic pain syndromes. A multidisciplinary approach is recommended. Study aim: To study the effectiveness of acupuncture as part of a multimodal treatment for women with vulvodynia and CPP. Des…
Sponsor: Medical University of Graz • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
New drug hopes to stop relapses in kids with rare nerve disease
Disease control OngoingThe primary purpose of this study is to evaluate the safety and efficacy of ravulizumab in pediatric participants with Neuromyelitis Optica Spectrum Disorder (NMOSD).
Phase 2/3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could two kidney drugs together be better than one?
Disease control CompletedFinerenone works by blocking a group of proteins, called mineralocorticoid receptor. An increased stimulation of mineralocorticoid receptor is known to trigger injury and inflammation in the kidney and is therefore thought to play a role in CKD. Empagliflozin lowers blood sugar …
Phase 2 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can paxlovid be safely used in pregnancy? a new trial investigates
Disease control Stopped earlyThe purpose of this clinical trial is to learn about how study medicine (Paxlovid, which contains nirmatrelvir and ritonavir) is changed and eliminated from the body, as well as its safety, and the extent to which side effects can be tolerated for treatment of pregnant women with…
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New ointment shows promise for rare skin condition
Disease control CompletedThis is a randomized, double-blind and vehicle-controlled Phase III study to evaluate the safety and efficacy of topical TMB-001 0.05% ointment for the treatment of congenital ichthyosis (CI) in subjects with either the RXLI or ARCI subtypes. In addition, a subset of preselected…
Phase 3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for Hard-to-Treat lymphoma: targeted drug shows promise
Disease control Recruiting nowThe purpose of this research study is to see if loncastuximab tesirine has any benefits at dose levels researchers found acceptable in earlier studies in patients with related forms of immune cell cancers. The researchers want to find out the effects (good and bad) that loncastux…
Phase 2 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Experimental Alzheimer's vaccine aims to clear brain plaques
Disease control Recruiting nowThe purpose of this study is to assess the safety, tolerability, immunogenicity and pharmacodynamic effects of ACI-24.060 in subjects with prodromal Alzheimer's disease and in non-demented adults with Down syndrome.
Phase 1/2 • Sponsor: AC Immune SA • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New mRNA vaccines for kids under 6 show promise in phase 3 trial
Vaccine CompletedThis study will evaluate the safety and immunogenicity of the mRNA-1273.214 vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concerns (VOCs) in participants aged 6 months to \<6 years, when administered as a primary series in SARS-CoV-2 vaccine-…
Phase 3 • Sponsor: ModernaTX, Inc. • Aim: Vaccine
Last updated Jun 27, 2026 08:00 UTC
-
Home workouts may boost fitness in liver disease
Disease control CompletedThe goal of this clinical trial is to evaluate whether home-based exercise interventions, including aerobic exercise (AE) and a combination of aerobic and resistance exercise (ARE), can improve physical and health-related outcomes in patients with chronic liver disease (CLD). The…
Sponsor: Hacettepe University • Aim: Disease control
Last updated Sep 09, 2026 23:00 UTC
-
Can a once-weekly shot protect joints in hemophilia a? new study aims to find out.
Disease control OngoingStudy MO42623 is a Phase IV, multicenter, open-label, three cohort study designed to evaluate the impact of emicizumab prophylaxis on overall health, physical activity, and joint outcomes in participants aged ≥13 and \<70 years with severe hemophilia A without factor VIII (FVIII)…
Phase 4 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Smart blood tests may personalize lung cancer care after targeted therapy
Disease control OngoingThis is an open-label, multi-center, randomized, phase III study. It is aimed to firstly evaluate the effectiveness and safety of almonertinib induction therapy in EGFR-mutated patients with unresectable stage III non-small cell lung cancer, and to evaluate the effectiveness and …
Phase 3 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New heart valve could save lives without Open-Heart surgery
Disease control Recruiting nowThe objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4/X4S Transcatheter Heart Valve (THV) in subjects with symptomatic, severe, calcific aortic stenosis (AS).
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
A softer path to stronger muscles for arthritis?
Symptom relief CompletedThis single-centre, randomized prospective interventional study assesses the effect of blood flow restriction training in patients with rheumatoid arthritis compared with conventional resistance training. In this prospective pilot study, patients with RA and PsA will be randomiz…
Sponsor: University of Bonn • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Treating Mom's depression may help Baby's brain
Disease control OngoingThe primary objective of this study is to determine if online group cognitive behavioral therapy (CBT) for maternal postpartum depression (PPD) added to treatment as usual (TAU) leads to greater improvements in infant emotion regulation (ER) than maternal receipt of TAU alone imm…
Sponsor: McMaster University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New shot could free teens with PKU from strict diet
Disease control OngoingThis is a Phase 3 open-label randomized controlled study enrolling approximately 54 adolescents with PKU. The study is designed to assess the safety and efficacy of pegvaliase injections.
Phase 3 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can a new biologic boost the immune System's fight against advanced tumors?
Disease control OngoingThe purpose of this study is to assess the safety and tolerability and to establish a preliminary recommended Phase 2 dose (RP2D) of MK-1484 administered as monotherapy and in combination with pembrolizumab (MK-3475) in adults with advanced or metastatic solid tumors.
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a vaccine help fight throat cancer? new trial tests promising combo
Disease control OngoingThis phase I/II trial studies how well PDS0101 alone or in combination with pembrolizumab works to shrink tumor in patients with human papillomavirus-associated oropharynx cancer that has spread to nearby tissue or lymph nodes (locally advanced). PDS0101 is a vaccine made from sp…
Phase 1/2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC